(Q36454493)

14 August 2017

Matrix metalloproteinase-2 dysregulation in type 1 diabetes (English)

1 reference

14 August 2017

0 references

Kathryn M Thrailkill

1

1 reference

14 August 2017

Robert C Bunn

2

1 reference

14 August 2017

Cynthia S Moreau

3

1 reference

14 August 2017

Gael E Cockrell

4

1 reference

14 August 2017

Pippa M Simpson

5

1 reference

14 August 2017

Hannah N Coleman

6

1 reference

14 August 2017

J Paul Frindik

7

1 reference

14 August 2017

Stephen F Kemp

8

1 reference

14 August 2017

John L Fowlkes

9

1 reference

14 August 2017

language of work or name

English

0 references

publication date

11 June 2007

1 reference

14 August 2017

1 reference

14 August 2017

30

1 reference

14 August 2017

9

1 reference

14 August 2017

2321-2326

1 reference

Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

Establishment of a diabetic mouse model with progressive diabetic nephropathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

Selective modulation of the secretion of proteinases and their inhibitors by growth factors in cultured differentiated podocytes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

Upregulated expression of human membrane type-5 matrix metalloproteinase in kidneys from diabetic patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

An empirical comparison of expert-derived and data-derived classification trees

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

A decision tree approach for carcinogen risk assessment.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in human type 2 diabetic arterial vasculature.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

Therapeutic potential of angiostatin in diabetic nephropathy

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

ERK-dependent signaling pathway and transcriptional factor Ets-1 regulate matrix metalloproteinase-9 production in transforming growth factor-beta1 stimulated glomerular podocytes

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

Screening for kidney disease in adults with diabetes

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

High glucose enhance expression of matrix metalloproteinase-2 in smooth muscle cells.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

Production and Activation of Matrix Metalloproteinase-2 in Proliferative Diabetic Retinopathy

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2239013

Myofibroblasts and the progression of diabetic nephropathy

21 September 2018

1 reference

12 December 2020

Characterization of matrix metalloproteinases in human urine: alterations during adolescence

1 reference

12 December 2020

Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease

1 reference

12 December 2020

Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus

1 reference

12 December 2020

High ambient glucose levels modulates the production of MMP-9 and alpha5(IV) collagen by cultured podocytes

1 reference

12 December 2020

Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy

1 reference

12 December 2020

Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats

1 reference

12 December 2020

High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1

1 reference

12 December 2020

Identifiers

DOI

10.2337/DC07-0162

1 reference

14 August 2017

1 reference

14 August 2017

1 reference